Evidence map›Paper›PMID 38348784›Full record

ArticleJournal of the American Heart Association2024

Rising Cardiac Troponin: A Prognostic Biomarker for Mortality After Acute Ischemic Stroke.

Michela Rosso, Srinath Ramaswamy, Yohannes Mulatu, Jessica N Little, Nino Kvantaliani, Ankita Brahmaroutu, Izabella Marczak, Jennifer Lewey, Rajat Deo, Steven R Messé and 3 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Michela RossoDepartment of Neurology University of Pennsylvania Philadelphia PA USA.ORCID 0000-0002-3359-9094
Srinath RamaswamyDepartment of Neurology Columbia University New York NY USA.
Yohannes MulatuDepartment of Neurology SUNY Downstate Health Sciences University Brooklyn NY USA.ORCID 0000-0002-3681-284X
Jessica N LittleDepartment of Neurology University of Pennsylvania Philadelphia PA USA.
Nino KvantalianiDepartment of Neurology Emory University Atlanta GA USA.
Ankita BrahmaroutuDepartment of Neurology University of Pennsylvania Philadelphia PA USA.
Izabella MarczakDepartment of Neurology SUNY Downstate Health Sciences University Brooklyn NY USA.ORCID 0000-0002-6711-9765
Jennifer LeweyDivision of Cardiology, Department of Medicine University of Pennsylvania Philadelphia PA USA.ORCID 0000-0003-3483-5527
Rajat DeoDivision of Cardiology, Department of Medicine University of Pennsylvania Philadelphia PA USA.ORCID 0000-0002-8250-2607
Steven R MesséDepartment of Neurology University of Pennsylvania Philadelphia PA USA.ORCID 0000-0003-3108-5441
Brett L CucchiaraDepartment of Neurology University of Pennsylvania Philadelphia PA USA.ORCID 0000-0002-5218-9015
Steven R LevineDepartment of Neurology SUNY Downstate Health Sciences University Brooklyn NY USA.ORCID 0000-0002-7451-7534
Scott E KasnerDepartment of Neurology University of Pennsylvania Philadelphia PA USA.ORCID 0000-0003-0418-6917

Funding

The Philadelphia Regional Stroke Trials Network Coordinating Center (PRSTNCC)U24NS107224 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Brett Lee Cucchiara · 2018 to 2026
$3.2M
NINDS NIH HHS U24 NS107224
6 · The paper itself

Abstract

backgroundElevated cardiac troponin (cTn) is detected in 10% to 30% of patients with acute ischemic stroke (AIS) and correlates with poor functional outcomes. Serial cTn measurements differentiate a dynamic cTn pattern (rise/fall >20%), specific for acute myocardial injury, from elevated but stable cTn levels (nondynamic), typically attributed to chronic cardiac/noncardiac conditions. We investigated if the direction of the cTn change (rising versus falling) affects mortality and outcome. METHODS AND

resultsWe retrospectively screened consecutive patients with AIS admitted to 5 stroke centers for elevated cTn at admission and at least 1 additional cTn measurement within 48 hours. The pattern of cTn was defined as rising if >20% increase from baseline, falling if >20% decrease, or nondynamic if ≤20% change in either direction. Logistic regression analyses were performed to assess the association of cTn patterns and 7-day mortality and unfavorable discharge disposition. Of 3789 patients with AIS screened, 300 were included. Seventy-two had a rising pattern, 66 falling, and 162 nondynamic. In patients with AIS with rising cTn, acute ischemic myocardial infarction was present in 54%, compared with 33% in those with falling cTn (

conclusionsRising cTn is independently associated with increased mortality and unfavorable discharge disposition in patients with AIS.

Indexed as

Ischemic StrokeMyocardial InfarctionBiomarkersHumansPrognosisRetrospective StudiesTroponinBiomarkersTroponincardiac complicationscardiac troponininsulaischemic strokemortality

Identifiers

PMID38348784
PMCPMC11010097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.